Insulin Aspart
Insulin Aspart
Definition
A recombinant human insulin analog with rapid-acting, blood glucose-lowering activity. Insulin aspart, acting faster than regular human insulin, regulates glucose metabolism by binding to insulin receptors on muscle and fat cells, thereby facilitating the cellular uptake of glucose. This lowers blood glucose levels. At the same time, insulin aspart inhibits the liver's conversion of stored glycogen into glucose, which also contributes to lower blood glucose levels. Insulin aspart also inhibits lipolysis in adipose tissue, inhibits proteolysis, and enhances protein synthesis. (NCI05)
Also known as INSULIN ASPART, Insulin Aspart Recombinant, Novolog — per NCIT
Also identified as
- ATC A10AB05 per RXNORM
- ATC A10AD05 per RXNORM
- NCIT NCIT:C47563 per NCIT
- SCTID 325072002 per RXNORM
- SCTID 388452006 per RXNORM
- UNII D933668QVX per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Diabetes mellitus type 2 | may treat | MEDRT · Public domain (U.S. Government work) |
| Hyperglycemia | may treat | MEDRT · Public domain (U.S. Government work) |
| Type 1 diabetes mellitus | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Alimentary part of gastrointestinal system | may treat a disease of this organ | DERIVED · CC BY 4.0 |
| Pancreas | may treat a disease of this organ | DERIVED · CC BY 4.0 |
2 entries above are marked DERIVED: Atlas Médico inferred them by combining two sourced claims, and no source asserts these links directly. Treat them as a navigation aid, not as a clinical statement.